Trial Profile
A Phase IV, Non comparative, Open label, Multicentric Trial to Evaluate the Safety and Efficacy of SYNRIAM in the Treatment of Acute Uncomplicated Plasmodium vivax
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Arterolane/piperaquine (Primary)
- Indications Malaria
- Focus Adverse reactions
- Sponsors Sun Pharmaceutical Industries
- 06 Sep 2016 New trial record